Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Kamila Rosiak"'
Autor:
Karolina Janik, Cezary Treda, Aneta Wlodarczyk, Joanna Peciak, Kamila Rosiak, Jolanta Zieba, Dagmara Grot, Adrianna Rutkowska, Roza Pawlowska, Waldemar Och, Piotr Rieske, Ewelina Stoczynska-Fidelus
Publikováno v:
BMC Cancer, Vol 19, Iss 1, Pp 1-16 (2019)
Abstract Background Glioblastoma (GB) is considered one of the most lethal tumors. Extensive research at the molecular level may enable to gain more profound insight into its biology and thus, facilitate development and testing of new therapeutic app
Externí odkaz:
https://doaj.org/article/e41314fc5a5142cb9707b47026fbd6e9
Autor:
Kelsey Pinkham, David Jaehyun Park, Arsalan Hashemiaghdam, Aleksandar B. Kirov, Isam Adam, Kamila Rosiak, Cintia C. da Hora, Jian Teng, Pike See Cheah, Litia Carvalho, Gitali Ganguli-Indra, Avalon Kelly, Arup K. Indra, Christian E. Badr
Publikováno v:
Stem Cell Reports, Vol 12, Iss 4, Pp 712-727 (2019)
Summary: Inherent plasticity and various survival cues allow glioblastoma stem-like cells (GSCs) to survive and proliferate under intrinsic and extrinsic stress conditions. Here, we report that GSCs depend on the adaptive activation of ER stress and
Externí odkaz:
https://doaj.org/article/9886afc7efdb4b3aba3936f75349e152
Autor:
Karolina Janik, Waldemar Och, Marta Popeda, Kamila Rosiak, Joanna Peciak, Piotr Rieske, Kamil Kulbacki, Blazej Szostak, Agnieszka Parda, Ewelina Stoczynska-Fidelus
Publikováno v:
Folia Neuropathologica, Vol 57, Iss 1, Pp 72-79 (2019)
Glioblastoma, the most malignant astrocytic tumour, is associated with limited survival and thus rare metastases. We analysed a particularly interesting case – a 51-year-old male diagnosed within 2 years with primary and recurrent glioblastoma, iso
Externí odkaz:
https://doaj.org/article/3805579c7ef248698199601441493995
Publikováno v:
PLoS ONE, Vol 15, Iss 9, p e0239325 (2020)
Mutation in isocitrate dehydrogenase 1 (IDH1R132H) occurs in various types of cancer, including low and high grade gliomas. Despite high incidence indicating its central role in tumor initiation and progression there are no targeted therapies directe
Externí odkaz:
https://doaj.org/article/5aaa754ce21241b3a34f76ca5e59e3b9
Autor:
Kamila Rosiak, Maciej Smolarz, Wojciech J Stec, Joanna Peciak, Dawid Grzela, Marta Winiecka-Klimek, Ewelina Stoczynska-Fidelus, Barbara Krynska, Sylwester Piaskowski, Piotr Rieske
Publikováno v:
PLoS ONE, Vol 11, Iss 5, p e0154726 (2016)
BACKGROUND:The high frequency of mutations in the isocitrate dehydrogenase 1 (IDH1) gene in diffuse gliomas indicates its importance in the process of gliomagenesis. These mutations result in loss of the normal function and acquisition of the neomorp
Externí odkaz:
https://doaj.org/article/43187015bea54ea4abddeca51682357d
Autor:
Kamila Rosiak, Pike See Cheah, Cintia Carla da Hora, Christian E. Badr, Isam Adam, Aleksandar B. Kirov, Avalon Kelly, Gitali Ganguli-Indra, Jian Teng, Arup K. Indra, Litia Carvalho, Arsalan Hashemiaghdam, David J. Park, Kelsey Pinkham
Publikováno v:
Stem Cell Reports, Vol 12, Iss 4, Pp 712-727 (2019)
Stem Cell Reports
Stem Cell Reports
Summary Inherent plasticity and various survival cues allow glioblastoma stem-like cells (GSCs) to survive and proliferate under intrinsic and extrinsic stress conditions. Here, we report that GSCs depend on the adaptive activation of ER stress and s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4cdcd00fbbeda305ae27e5274158fe9d
https://doi.org/10.1016/j.stemcr.2019.02.012
https://doi.org/10.1016/j.stemcr.2019.02.012
Autor:
Ewelina Stoczynska-Fidelus, Agnieszka Parda, Piotr Rieske, Karolina Janik, Kamil Kulbacki, Waldemar Och, Marta Popęda, Blazej Szostak, Joanna Peciak, Kamila Rosiak
Publikováno v:
Folia Neuropathologica, Vol 57, Iss 1, Pp 72-79 (2019)
Glioblastoma, the most malignant astrocytic tumour, is associated with limited survival and thus rare metastases. We analysed a particularly interesting case - a 51-year-old male diagnosed within 2 years with primary and recurrent glioblastoma, isoci
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::337ea8e2e51ce8fa35216447288a6711
https://www.termedia.pl/Glioblastoma-with-BRAFV600E-mutation-and-numerous-metastatic-foci-a-case-report,20,36147,1,1.html
https://www.termedia.pl/Glioblastoma-with-BRAFV600E-mutation-and-numerous-metastatic-foci-a-case-report,20,36147,1,1.html
Autor:
Wojciech J. Stec, Cezary Treda, Marcin Pacholczyk, Piotr Rieske, Kamila Rosiak, Maciej Smolarz, Joanna Peciak, Ewelina Stoczynska-Fidelus, Anna Lenart, Dawid P. Grzela
Publikováno v:
Oncotarget
Despite intensive research no therapies targeted against the oncogenic EGFRvIII are present in the clinic. One of the reasons is the elusive nature of the molecular structure and activity of the truncated receptor. The recent publications indicate th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::10323d35333bb47a9e206f5478f1a59d
http://europepmc.org/articles/PMC5823601
http://europepmc.org/articles/PMC5823601
Autor:
Piotr Rieske, Wojciech J. Stec, Joanna Peciak, Krystyna Hulas-Bigoszewska, Cezary Treda, Waldemar Och, Kamila Rosiak, Marta Popęda, Maciej Smolarz, Ewelina Stoczynska-Fidelus, Magdalena Ksiazkiewicz, Karolina Janik
Publikováno v:
Journal of Cancer
Background: The presence as well as the potential role of EGFRvIII in tumors other than glioblastoma still remains a controversial subject with many contradictory data published. Previous analyses, however, did not consider the level of EGFRvIII mRNA
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::18dc7cbf43bdaafdc42fb82e8d6fe40c
http://europepmc.org/articles/PMC5264051
http://europepmc.org/articles/PMC5264051
Autor:
Aneta Wlodarczyk, Jolanta Zieba, Piotr Rieske, Roza Pawlowska, Ewelina Stoczynska-Fidelus, Karolina Janik, Cezary Treda, Dagmara Grot, Waldemar Och, Adrianna Rutkowska, Kamila Rosiak, Joanna Peciak
Publikováno v:
BMC Cancer
BMC Cancer, Vol 19, Iss 1, Pp 1-16 (2019)
BMC Cancer, Vol 19, Iss 1, Pp 1-16 (2019)
Background Glioblastoma (GB) is considered one of the most lethal tumors. Extensive research at the molecular level may enable to gain more profound insight into its biology and thus, facilitate development and testing of new therapeutic approaches.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a61499a6d465cf8764a01de6869fed68
https://pubmed.ncbi.nlm.nih.gov/31521143
https://pubmed.ncbi.nlm.nih.gov/31521143